在慢性病的小鼠模型中,TLR4抑制减轻了血管重塑
Tomohiro Shirouzu1, Jun-Ichiro Koga1, Nasanbadrakh Orkhonselenge1
1The Second Department of Internal Medicine, University of Occupational and Environmental Health, Japan.
Journal of atherosclerosis and thrombosis
|February 1, 2026
概括
收费类受体4 (TLR4) 信号驱动慢性病 (CKD) 的血管重塑. 抑制TLR4可减少血管变化和炎症,为CKD患者提供潜在的治疗点.
科学领域:
- 心血管生物学 心血管生物学
- 腎臟病學 (nephrology) 是一種醫學專業.
- 免疫学 免疫学 免疫学
背景情况:
- 慢性病 (CKD) 与加速的血管改造有关,包括中间体加厚和纤维化.
- 在CKD驱动的血管改造背后的精确分子机制尚未完全理解.
研究的目的:
- 研究托尔类受体4 (TLR4) 在与CKD相关的血管重塑中的作用.
- 在CKD小鼠模型中评估TLR4抑制的治疗潜力.
主要方法:
- 一个5/6腎切除小鼠模型被用于诱导CKD.
- 使用特定的小分子抑制剂TAK-242抑制了TLR4信号传输.
- 评估了血管重塑,巨细胞积累,细胞增殖和炎症标志物.
主要成果:
- 不管血压如何,TLR4阻塞显著降低了大动脉中枢厚化和周血管纤维化.
- 抑制TLR4降低了巨细胞的积累和细胞在主动脉中的增殖.
- TLR4阻塞抑制了Interleukin-6 (IL-6) mRNA表达,并减少了CKD血清诱导的IL-6表达和血管光滑肌肉细胞生长.
结论:
- 在CKD中,TLR4介导的无菌炎症有助于血管重塑.
- 针对TLR4信号提供了一个潜在的治疗策略,以减轻CKD中的心血管并发症.
相关概念视频
Chronic Kidney Disease I: Introduction
728
Chronic Kidney Disease (CKD) arises when the kidneys progressively lose their ability to function, ultimately leading to end-stage renal disease. At this advanced stage, the kidneys can no longer filter waste or maintain essential body functions, requiring renal replacement therapy (RRT) through dialysis or a kidney transplant for survival.Early-stage chronic kidney disease and detection challengesIn CKD's early stages, symptoms often remain absent because healthy nephrons compensate for...
728
Chronic Kidney Disease II: Clinical Manifestations
653
Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
653
Chronic Kidney Disease III: Interprofessional Care
472
Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
472
Chronic Kidney Disease IV: Nursing Management
392
Nursing management is essential for preventing complications, maintaining stability, and improving patients' quality of life in chronic kidney disease (CKD). By using a structured approach, nurses help slow CKD progression and support effective patient care.1. Comprehensive patient assessmentEffective management begins with nurses reviewing the patient’s medical history, and identifying key risk factors like diabetes, hypertension, and nephrotoxic drug use. Nurses assess signs of...
392
Nucleosome Remodeling
11.2K
Nucleosomes are the basic units of chromatin compaction. Each nucleosome consists of the DNA bound tightly around a histone core, which makes the DNA inaccessible to DNA binding proteins such as DNA polymerase and RNA polymerase. Hence, the fundamental problem is to ensure access to DNA when appropriate, despite the compact and protective chromatin structure.
Nucleosome remodeling complex
Eukaryotic cells have specialized enzymes called ATP-dependent nucleosome remodeling enzymes. These enzymes...
Nucleosome remodeling complex
Eukaryotic cells have specialized enzymes called ATP-dependent nucleosome remodeling enzymes. These enzymes...
11.2K
Transcription Attenuation in Prokaryotes
18.5K
Transcriptional attenuation occurs when RNA transcription is prematurely terminated due to the formation of a terminator mRNA hairpin structure. Bacteria use these hairpins to regulate the transcription process and control the synthesis of several amino acids including histidine, lysine, threonine, and phenylalanine. Transcription attenuation takes place in the non-coding regions of mRNA.
There are several different mechanisms used to attenuate transcription. In ribosome mediated...
There are several different mechanisms used to attenuate transcription. In ribosome mediated...
18.5K


